Evidence map›Paper›PMID 27402857›Full record

ArticleJournal of neurointerventional surgery2017

Endovascular treatment of acute ischemic stroke in nonagenarians compared with younger patients in a multicenter cohort.

Muhib A Khan, Grayson L Baird, David Miller, Anand Patel, Shawn Tsekhan, Shadi Yaghi, Ajit Puri, Mahesh Jayaraman, Nils Henninger, Brian Silver

Open access · greenAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of neurointerventional surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Muhib A KhanDepartment of Neurology, Brown University, Providence, Rhode Island, USA.
Grayson L BairdLifespan Biostatistics Core, Lifespan Hospital System, Providence, Rhode Island, USA.ORCID http://orcid.org/0000-0002-5926-9886
David MillerDepartment of Neurology, Brown University, Providence, Rhode Island, USA.ORCID http://orcid.org/0000-0003-4905-5128
Anand PatelDepartment of Neurology, University of Massachusetts, Worcester, Massachusetts, USA.
Shawn TsekhanDepartment of Neurology, Brown University, Providence, Rhode Island, USA.
Shadi YaghiDepartment of Neurology, Brown University, Providence, Rhode Island, USA.
Ajit PuriDepartment of Radiology, University of Massachusetts, Worcester, Massachusetts, USA.
Mahesh JayaramanDepartment of Diagnostic Imaging, Brown University, Providence, Rhode Island, USA.
Nils HenningerDepartment of Neurology, University of Massachusetts, Worcester, Massachusetts, USA.
Brian SilverDepartment of Neurology, Brown University, Providence, Rhode Island, USA.ORCID http://orcid.org/0000-0002-1562-9894
Brown University · USUniversity of Massachusetts Chan Medical School · USSpectrum Health · US

Funding

Inhibiting axon degeneration in a mouse model of acute brain injury through deletion of Sarm1K08NS091499 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HENNINGER, NILS · 2016 to 2020
$919k
NINDS NIH HHS K08 NS091499
6 · The paper itself

Abstract

backgroundRecent studies have demonstrated the superiority of endovascular therapy (EVT) for emergent large vessel occlusion.

objectiveTo determine the effectiveness of EVT in nonagenarians, for whom data are limited.

methodsWe retrospectively reviewed clinical and imaging data of all patients who underwent EVT at two stroke centers between January 2012 and August 2014. The 90-day functional outcome (modified Rankin Scale (mRS) score) was compared between younger patients (age 18-89 years; n=175) and nonagenarians (n=18). The relationship between pre-stroke and 90-day post-stroke mRS was analyzed in these two groups. Multivariable analysis of age, recanalization grade, and admission National Institutes of Health Stroke Scale (NIHSS) for predicting outcome was performed.

resultsAge ≥90 years was associated with a poor (mRS >2) 90-day outcome relative to those under 90 (89% vs 52%, OR=8, 95% CI 1.7 to 35.0; p=0.0081). Nonagenarians had a higher pre-stroke mRS score (0.77; 95% CI 0.44 to 1.30) than younger patients (0.24; 95% CI 0.17 to 0.35; p=0.005). No difference was observed between nonagenarians and younger patients in the rate of mRS change from pre-stroke to 90 days (p=0.540). On multivariable regression, age (OR=1.05, 95% CI 1.03 to 1.08; p<0.0001), recanalization grade (OR=0.62 95% CI 0.42 to 0.91; p=0.015), and admission NIHSS (OR=1.07 95% CI 1.02 to 1.13; p=0.01) were associated with a poor 90-day outcome.

conclusionsNonagenarians are at a substantially higher risk of a poor 90-day outcome after EVT than younger patients. However, a small subset of nonagenarians may benefit from EVT, particularly if they have a good pre-stroke functional status. Further research is needed to identify factors associated with favorable outcome in this age cohort.

Indexed as

AdolescentAdultAgedAged, 80 and overBrain IschemiaCohort StudiesEndovascular ProceduresFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesStrokeTreatment OutcomeYoung AdultAngiographyInterventionStrokeThrombectomy

Identifiers

PMID27402857
PMCPMC5226916
OpenAlexW2472491940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.